Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06648252 · ClinicalTrials.gov registry record · NA

Healing Minds: Biofeedback and Breathing Practices in Children and Adolescents With ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Hoskinson Health and Wellness Clinic.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06648252: Completed NA study of Attention Deficit Hyperactivity Disorder, sponsored by Hoskinson Health and Wellness Clinic.

NCT06648252 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Hoskinson Health and Wellness Clinic. The registered enrollment target is 12 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06648252, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Hoskinson Health and Wellness Clinic.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The objective of this research proposal is to examine the combined effects of an integrative approach including biofeedback and breathing practices (Healing Minds) on severity of Attention Deficit Hyperactivity Disorder (ADHD) in youth 6-18 years of age. The investigators hypothesize that ADHD severity will be significantly reduced and Heart Rate Variability (HRV) increased after participation in the 10-week intervention. The investigators also propose that ADHD severity in those patients with prescribed medication but poorly-controlled ADHD will demonstrate the greatest improvement compared to those not prescribed medication and those who have well-controlled ADHD. Our specific aims are as follows: AIM I. Conduct a randomized, placebo-controlled trial (RCT) to examine the effects of a 10-week integrative intervention (Healing Minds) that includes Heart Math Biofeedback and Breathing Practices on ADHD severity and HRV in children and adolescents 6-18 years of age diagnosed with ADHD (N=40). Participants randomized to placebo will be placed on a delayed intervention waiting list and will receive the 10-week Healing Minds intervention afterwards. Hypothesis I: ADHD severity will be significantly reduced and HRV increased following the 10-week Healing Minds Intervention in children and adolescents, 6-18 years of age diagnosed with ADHD compared to a placebo condition AIM Ia. Observe the effects of the Healing Minds intervention in the following sub-groups of youth: ADHD without medication (well versus poorly controlled) ADHD with medication (well versus poorly controlled) Hypothesis Ia: Participants without medication will experience a significantly greater reduction in ADHD severity compared to those with medication. Poorly controlled participants with medication will experience the greatest reduction in ADHD severity. AIM Ib. Explore the effects of the intervention on related mental health conditions: PTSD Anxiety Resilience

Primary Outcome

The Conner's Abbreviated Parents Rating Scale

Interventions

  • BEHAVIORAL Healing Minds Biofeedback and Breathing Practices Intervention

Study Locations (1)

Wyoming

  • Hoskinson Health and Wellness Clinic - Gillette

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-07-08
Est. Completion 2025-01-10
Phase NA

What the finished NCT06648252 record still lists

NCT06648252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Healing Minds Biofeedback and Breathing Practices Intervention is the first listed.

NCT06648252 reports a single indexed study location in Wyoming.

Frequently Asked Questions

What is clinical trial NCT06648252 about?

NCT06648252 is a clinical study titled "Healing Minds: Biofeedback and Breathing Practices in Children and Adolescents With ADHD". The objective of this research proposal is to examine the combined effects of an integrative approach including biofeedback and breathing practices (Healing Minds) on severity of Attention Deficit Hyperactivity Disorder (ADHD) in youth 6-18 years of age. The investigators hypothesize that ADHD sever...

What is the current status of trial NCT06648252?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-07-08. Estimated completion is 2025-01-10.

What conditions does trial NCT06648252 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT06648252?

The interventions under investigation include: Healing Minds Biofeedback and Breathing Practices Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06648252?

This trial is sponsored by Hoskinson Health and Wellness Clinic, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06648252 being conducted?

This trial has 1 study location across Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06648252's enrollment target sits among peer trials

12 101st of 102 higher than 2 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06648252, the US trial registry maintained by the National Library of Medicine. NCT06648252 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.